With the aim to compare the pain medicines bupivacaine and liposomal bupivacaine, minimally invasive lobectomy patients were randomly assigned to either medicine and monitored after surgery. Both postoperative pain level and treatment cost were compared. The study concluded that the morphine use, long-term narcotic use, and overall cost metrics between bupivacaine and LipoB were similar.
You are here:
Randomized Trial of Bupivacaine Versus Liposomal Bupivacaine in Minimally Invasive Lobectomy
Submitted by: Cameron Lind
Source: The Annals of Cardiothoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2022.02.058
Keywords:
Author(s): Sowmyanarayanan Thuppal, MD, PhD; Anthony Sleiman, BA; Kanika Chawla, MD; Danuta Dynda, MD; Quadis Evans, BS; Stephen Markwell, MA; Stephen Hazelrigg, MD; Traves Crabtree, MD
